Corresponding Author: Meera Viswanathan, PhD, RTI International, 3040 E Cornwallis Rd, Research Triangle Park, NC 27709 (viswanathan@rti.org).
Accepted for Publication: August 25, 2022.
Published Online: October 11, 2022. doi:10.1001/jama.2022.16310
Author Contributions: Dr Viswanathan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Viswanathan, Kahwati.
Acquisition, analysis, or interpretation of data: Viswanathan, Wallace, Cook Middleton, Kennedy, McKeeman, Hudson, Rains, Vander Schaaf.
Drafting of the manuscript: Viswanathan, Kennedy, Rains.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Viswanathan, Wallace, Kahwati.
Obtained funding: Viswanathan, Kahwati.
Administrative, technical, or material support: Viswanathan, Kennedy, Rains.
Supervision: Viswanathan.
Conflict of Interest Disclosures: Dr Vander Schaaf reported that she is a Fellow of the American Academy of Pediatrics and member of American Academy of Pediatrics CATCH Committee. No other disclosures were reported.
Funding/Support: This study was funded under contract HHSA-290-2015-00011-I, Task Order 15, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (HHS), under a contract to support the US Preventive Services Task Force (USPSTF).
Role of the Funder/Sponsor: Investigators worked with USPSTF members and AHRQ staff to develop the scope, analytic framework, and key questions for this review. AHRQ had no role in study selection, quality assessment, or synthesis. AHRQ staff provided project oversight, reviewed the report to ensure that the analysis met methodological standards, and distributed the draft for peer review. Otherwise, AHRQ had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript findings. The opinions expressed in this document are those of the authors and do not represent the official position of AHRQ or HHS.
Additional Contributions: We acknowledge the following individuals for their contributions to this project: AHRQ staff Iris Mabry-Hernandez, MD, MPH, and Tracy Wolf, MD, MPH; current and former members of the USPSTF who contributed to topic deliberations; RTI International–University of North Carolina Evidence-based Practice Center staff Christiane Voisin, MSLS, Candi Wines, MPH, Nila A. Sathe, MA, MLIS, Carol Woodell, BSPH, Sharon Barrell, MA, Staci Rachman, BA, Michelle Bogus, Sarah Barringer, and Loraine Monroe. USPSTF members, peer reviewers, and federal partner reviewers did not receive financial compensation for their contributions.
Additional Information: A draft version of the full evidence report underwent external peer review from 4 content experts (Gregory Simon, MD, MPH, University of Washington; Joan Asarnow, PhD, University of California, Los Angeles; Natalie Cort, PhD, William James College; and Raquel Halfond, PhD, American Psychological Association) and a federal partner reviewer (Erin Abramsohn, DrPH, MPH, Centers for Disease Control and Prevention). Comments from reviewers were presented to the USPSTF during its deliberation of the evidence and were considered in preparing the final evidence review.
Editorial Disclaimer: This evidence report is presented as a document in support of the accompanying USPSTF recommendation statement. It did not undergo additional peer review after submission to JAMA.
1.Wilson
S , Hicks
BM , Foster
KT , McGue
M , Iacono
WG . Age of onset and course of major depressive disorder: associations with psychosocial functioning outcomes in adulthood.
Psychol Med. 2015;45(3):505-514. doi:
10.1017/S0033291714001640PubMedGoogle ScholarCrossref 2.Whalen
DJ , Dixon-Gordon
K , Belden
AC , Barch
D , Luby
JL . Correlates and consequences of suicidal cognitions and behaviors in children ages 3 to 7 years.
J Am Acad Child Adolesc Psychiatry. 2015;54(11):926-37. doi:
10.1016/j.jaac.2015.08.009PubMedGoogle ScholarCrossref 5.Siu
AL ; US Preventive Services Task Force. Screening for depression in children and adolescents: US Preventive Services Task Force recommendation statement.
Ann Intern Med. 2016;164(5):360-366. doi:
10.7326/M15-2957PubMedGoogle ScholarCrossref 6.LeFevre
ML ; US Preventive Services Task Force. Screening for suicide risk in adolescents, adults, and older adults in primary care: US Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;160(10):719-726. doi:
10.7326/M14-0589PubMedGoogle ScholarCrossref 8.Viswanathan
M , Wallace
I , Cook Middleton
J ,
et al. Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents: An Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 221. Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05293-EF-1.
9.Forman-Hoffman
V , McClure
E , McKeeman
J ,
et al. Screening for major depressive disorder in children and adolescents: a systematic review for the US Preventive Services Task Force.
Ann Intern Med. 2016;164(5):342-349. doi:
10.7326/M15-2259PubMedGoogle ScholarCrossref 10.O’Connor
E , Gaynes
B , Burda
BU , Williams
C , Whitlock
EP . Screening for suicide risk in primary care: a systematic evidence review for the US Preventive Services Task Force. Agency for Healthcare Research and Quality; 2013.
12.Viswanathan
M , Kennedy
SM , McKeeman
J ,
et al. Treatment of Depression in Children and Adolescents: A Systematic Review. AHRQ Comparative Effectiveness Review No. 224. Agency for Healthcare Research and Quality; 2020. AHRQ publication 20-EHC005-EF.
18.Deeks
J , Higgins
J , Altman
DG ; Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V, eds.
Cochrane Handbook for Systematic Reviews of Interventions. Cochrane. Published 2022. Accessed August 31, 2022.
https://training.cochrane.org/handbook 20.Viswanathan
M , Wallace
IF , Cook Middleton
J ,
et al. Screening for anxiety in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force.
JAMA. Published October 11, 2022. doi:
10.1001/jama.2022.16303Google Scholar 21.Canals
J , Bladé
J , Carbajo
G , Domènech-Llabería
E . The Beck Depression Inventory: psychometric characteristics and usefulness in nonclinical adolescents.
Eur J Psychol Assess. 2001;17(1):63-68. doi:
10.1027//1015-5759.17.1.63Google ScholarCrossref 24.Johnson
JG , Harris
ES , Spitzer
RL , Williams
JBW . The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients.
J Adolesc Health. 2002;30(3):196-204. doi:
10.1016/S1054-139X(01)00333-0PubMedGoogle ScholarCrossref 26.Patton
GC , Coffey
C , Posterino
M , Carlin
JB , Wolfe
R , Bowes
G . A computerised screening instrument for adolescent depression: population-based validation and application to a two-phase case-control study.
Soc Psychiatry Psychiatr Epidemiol. 1999;34(3):166-172. doi:
10.1007/s001270050129PubMedGoogle ScholarCrossref 32.Fristad
MA , Vesco
AT , Young
AS ,
et al. Pilot randomized controlled trial of omega-3 and individual-family psychoeducational psychotherapy for children and adolescents with depression.
J Clin Child Adolesc Psychol. 2019;48(suppl 1):S105-S118. doi:
10.1080/15374416.2016.1233500PubMedGoogle ScholarCrossref 34.March
J , Silva
S , Petrycki
S ,
et al; Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
JAMA. 2004;292(7):807-820. doi:
10.1001/jama.292.7.807PubMedGoogle ScholarCrossref 37.Topooco
N , Berg
M , Johansson
S ,
et al. Chat- and internet-based cognitive-behavioural therapy in treatment of adolescent depression: randomised controlled trial.
BJPsych Open. 2018;4(4):199-207. doi:
10.1192/bjo.2018.18PubMedGoogle ScholarCrossref 38.Topooco
N , Byléhn
S , Dahlström Nysäter
E ,
et al. Evaluating the efficacy of internet-delivered cognitive behavioral therapy blended with synchronous chat sessions to treat adolescent depression: randomized controlled trial.
J Med Internet Res. 2019;21(11):e13393. doi:
10.2196/13393PubMedGoogle ScholarCrossref 40.Lindqvist
K , Mechler
J , Carlbring
P ,
et al. Affect-focused psychodynamic internet-based therapy for adolescent depression: randomized controlled trial.
J Med Internet Res. 2020;22(3):e18047. doi:
10.2196/18047PubMedGoogle ScholarCrossref 41.Findling
RL , Robb
A , Bose
A . Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
J Child Adolesc Psychopharmacol. 2013;23(7):468-480. doi:
10.1089/cap.2012.0023PubMedGoogle ScholarCrossref 42.Hoyniak
CP , Whalen
DJ , Barch
D , Luby
JL . Sleep problems in preschool-onset major depressive disorder: the effect of treatment with parent-child interaction therapy-emotion development.
Eur Child Adolesc Psychiatry. 2021;30(9):1463-1474. doi:
10.1007/s00787-020-01641-1PubMedGoogle ScholarCrossref 47.McGlinchey
EL , Reyes-Portillo
JA , Turner
JB , Mufson
L . Innovations in practice: the relationship between sleep disturbances, depression, and interpersonal functioning in treatment for adolescent depression.
Child Adolesc Ment Health. 2017;22(2):96-99. doi:
10.1111/camh.12176PubMedGoogle ScholarCrossref 51.Robinson
J , Pan Yuen
H , Martin
C ,
et al. Does screening high school students for psychological distress, deliberate self-harm, or suicidal ideation cause distress—and is it acceptable? an Australian-based study.
Crisis. 2011;32(5):254-263. doi:
10.1027/0227-5910/a000087PubMedGoogle ScholarCrossref 53.Cottrell
DJ , Wright-Hughes
A , Collinson
M ,
et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial.
Lancet Psychiatry. 2018;5(3):203-216. doi:
10.1016/S2215-0366(18)30058-0PubMedGoogle ScholarCrossref 54.Cottrell
DJ , Wright-Hughes
A , Collinson
M ,
et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention–Family Therapy (SHIFT) trial.
Health Technol Assess. 2018;22(12):1-222. doi:
10.3310/hta22120PubMedGoogle ScholarCrossref 55.Cottrell
DJ , Wright-Hughes
A , Eisler
I ,
et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow up of pragmatic randomised controlled trial.
EClinicalMedicine. 2020;18:100246. doi:
10.1016/j.eclinm.2019.100246PubMedGoogle ScholarCrossref 62.King
CA , Klaus
N , Kramer
A , Venkataraman
S , Quinlan
P , Gillespie
B . The Youth-Nominated Support Team–Version II for suicidal adolescents: a randomized controlled intervention trial.
J Consult Clin Psychol. 2009;77(5):880-893. doi:
10.1037/a0016552PubMedGoogle ScholarCrossref 63.King
CA , Arango
A , Kramer
A ,
et al; YST Study Team. Association of the youth-nominated support team intervention for suicidal adolescents with 11- to 14-year mortality outcomes: secondary analysis of a randomized clinical trial.
JAMA Psychiatry. 2019;76(5):492-498. doi:
10.1001/jamapsychiatry.2018.4358PubMedGoogle ScholarCrossref 66.Mehlum
L , Ramberg
M , Tørmoen
AJ ,
et al. Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up.
J Am Acad Child Adolesc Psychiatry. 2016;55(4):295-300. doi:
10.1016/j.jaac.2016.01.005PubMedGoogle ScholarCrossref 67.Mehlum
L , Ramleth
RK , Tørmoen
AJ ,
et al. Long term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior.
J Child Psychol Psychiatry. 2019;60(10):1112-1122. doi:
10.1111/jcpp.13077PubMedGoogle ScholarCrossref 68.Haga
E , Aas
E , Grøholt
B , Tørmoen
AJ , Mehlum
L . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm.
Child Adolesc Psychiatry Ment Health. 2018;12:22. doi:
10.1186/s13034-018-0227-2PubMedGoogle ScholarCrossref 70.Ougrin
D , Zundel
T , Ng
A , Banarsee
R , Bottle
A , Taylor
E . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self-harm.
Arch Dis Child. 2011;96(2):148-153. doi:
10.1136/adc.2010.188755PubMedGoogle ScholarCrossref 77.Aboustate
N , Raven
M , Klau
J , Jureidini
J . Reanalysis of the Treatment for Adolescents with Depression Study (TADS) under the restoring invisible and abandoned trials initiative (RIAT).
BMJ Evid Based Med. 2019;24:A20-A21. doi:
10.1136/bmjebm-2019-POD.42Google Scholar